» Articles » PMID: 33777782

Aberrations of Genomic Imprinting in Glioblastoma Formation

Overview
Journal Front Oncol
Specialty Oncology
Date 2021 Mar 29
PMID 33777782
Citations 6
Authors
Affiliations
Soon will be listed here.
Abstract

In human glioblastoma (GBM), the presence of a small population of cells with stem cell characteristics, the glioma stem cells (GSCs), has been described. These cells have GBM potential and are responsible for the origin of the tumors. However, whether GSCs originate from normal neural stem cells (NSCs) as a consequence of genetic and epigenetic changes and/or dedifferentiation from somatic cells remains to be investigated. Genomic imprinting is an epigenetic marking process that causes genes to be expressed depending on their parental origin. The dysregulation of the imprinting pattern or the loss of genomic imprinting (LOI) have been described in different tumors including GBM, being one of the earliest and most common events that occurs in human cancers. Here we have gathered the current knowledge of the role of imprinted genes in normal NSCs function and how the imprinting process is altered in human GBM. We also review the changes at particular imprinted loci that might be involved in the development of the tumor. Understanding the mechanistic similarities in the regulation of genomic imprinting between normal NSCs and GBM cells will be helpful to identify molecular players that might be involved in the development of human GBM.

Citing Articles

The role of imprinting genes' loss of imprints in cancers and their clinical implications.

Xie G, Si Q, Zhang G, Fan Y, Li Q, Leng P Front Oncol. 2024; 14:1365474.

PMID: 38812777 PMC: 11133587. DOI: 10.3389/fonc.2024.1365474.


Hypomethylation at H19DMR in penile squamous cell carcinoma is not related to HPV infection.

da Silva Santos R, Pinheiro D, Hirth C, Bezerra M, Silva-Fernandes I, da Silva Oliveira F Epigenetics. 2024; 19(1):2305081.

PMID: 38245880 PMC: 10802203. DOI: 10.1080/15592294.2024.2305081.


EpiTyping: analysis of epigenetic aberrations in parental imprinting and X-chromosome inactivation using RNA-seq.

Sarel-Gallily R, Keshet G, Kinreich S, Haim-Abadi G, Benvenisty N Nat Protoc. 2023; 18(12):3881-3917.

PMID: 37914783 DOI: 10.1038/s41596-023-00898-5.


An update on the molecular biology of glioblastoma, with clinical implications and progress in its treatment.

Verdugo E, Puerto I, Medina M Cancer Commun (Lond). 2022; 42(11):1083-1111.

PMID: 36129048 PMC: 9648390. DOI: 10.1002/cac2.12361.


Genomic Imprinting in the New Omics Era: A Model for Systems-Level Approaches.

Hubert J, Demars J Front Genet. 2022; 13:838534.

PMID: 35368671 PMC: 8965095. DOI: 10.3389/fgene.2022.838534.


References
1.
Bowman R, Wang Q, Carro A, Verhaak R, Squatrito M . GlioVis data portal for visualization and analysis of brain tumor expression datasets. Neuro Oncol. 2016; 19(1):139-141. PMC: 5193031. DOI: 10.1093/neuonc/now247. View

2.
Chen R, Smith-Cohn M, Cohen A, Colman H . Glioma Subclassifications and Their Clinical Significance. Neurotherapeutics. 2017; 14(2):284-297. PMC: 5398991. DOI: 10.1007/s13311-017-0519-x. View

3.
Perrera V, Martello G . How Does Reprogramming to Pluripotency Affect Genomic Imprinting?. Front Cell Dev Biol. 2019; 7:76. PMC: 6521591. DOI: 10.3389/fcell.2019.00076. View

4.
Livingstone C . IGF2 and cancer. Endocr Relat Cancer. 2013; 20(6):R321-39. DOI: 10.1530/ERC-13-0231. View

5.
Ferguson-Smith A . Genomic imprinting: the emergence of an epigenetic paradigm. Nat Rev Genet. 2011; 12(8):565-75. DOI: 10.1038/nrg3032. View